ORBIMED ADVISORS LLC Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for January 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2018 | TORC | resTORbio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,871,569 | 0 | 0 | |
| Jan 30 2018 | TORC | resTORbio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,425,482 | 0 | 0 | |
| Jan 30 2018 | TORC | resTORbio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 15.00 | 533,333 | 7,999,995 | 4,830,387 | 4.3 M to 4.8 M (+12.41 %) |
| Jan 30 2018 | TORC | resTORbio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,871,569 | 0 | 4,297,054 | 2.4 M to 4.3 M (+77.16 %) |
| Jan 30 2018 | TORC | resTORbio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,425,485 | 0 | 2,425,485 | 0 to 2.4 M |
| Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 31,315 | 0 | 0 | |
| Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 45,961 | 0 | 0 | |
| Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 332,271 | 0 | 0 | |
| Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 283,627 | 0 | 0 | |
| Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 415,869 | 0 | 0 | |
| Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,226,156 | 0 | 0 | |
| Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,783,704 | 0 | 0 | |
| Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 409,547 | 0 | 409,547 | 0 to 409.5 K |
| Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 3,709,356 | 0 | 3,709,356 | 0 to 3.7 M |
| Jan 30 2018 | MIRN | SYNLOGIC, INC. | ORBIMED ADVISORS LLC | Director | Grant | A | 9.75 | 715,000 | 6,971,250 | 2,029,996 | 1.3 M to 2 M (+54.37 %) |
| Jan 30 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.99 | 50,000 | 749,500 | 3,022,760 | 3 M to 3 M (+1.68 %) |
| Jan 30 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.93 | 22,760 | 339,807 | 2,972,760 | 3 M to 3 M (+0.77 %) |
| Jan 24 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.91 | 64,637 | 963,738 | 2,950,000 | 2.9 M to 3 M (+2.24 %) |
| Jan 24 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.99 | 4,363 | 65,401 | 2,885,363 | 2.9 M to 2.9 M (+0.15 %) |
| Jan 24 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.98 | 75,000 | 1,123,500 | 2,881,000 | 2.8 M to 2.9 M (+2.67 %) |
| Jan 24 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.95 | 74,931 | 1,120,218 | 2,806,000 | 2.7 M to 2.8 M (+2.74 %) |
| Jan 24 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.50 | 38,354 | 556,133 | 2,731,069 | 2.7 M to 2.7 M (+1.42 %) |
| Jan 24 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.91 | 64,637 | 963,738 | 2,950,000 | 2.9 M to 3 M (+2.24 %) |
| Jan 24 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.99 | 4,363 | 65,401 | 2,885,363 | 2.9 M to 2.9 M (+0.15 %) |
| Jan 24 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.98 | 75,000 | 1,123,500 | 2,881,000 | 2.8 M to 2.9 M (+2.67 %) |
| Jan 24 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.95 | 74,931 | 1,120,218 | 2,806,000 | 2.7 M to 2.8 M (+2.74 %) |
| Jan 24 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.50 | 38,354 | 556,133 | 2,731,069 | 2.7 M to 2.7 M (+1.42 %) |
| Jan 12 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 15.40 | 28,446 | 438,068 | 2,692,715 | 2.7 M to 2.7 M (+1.07 %) |
| Jan 12 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 13.65 | 41,700 | 569,205 | 2,664,269 | 2.6 M to 2.7 M (+1.59 %) |
| Jan 12 2018 | KALA | Kala Pharmaceutica ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 12.83 | 170,338 | 2,185,437 | 2,622,569 | 2.5 M to 2.6 M (+6.95 %) |
| Jan 04 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.35 | 16,128 | 118,541 | 49,270 | 65.4 K to 49.3 K (-24.66 %) |
| Jan 04 2018 | PIRS | PIERIS PHARMACEUTI ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.35 | 1,693,492 | 12,447,166 | 5,500,730 | 7.2 M to 5.5 M (-23.54 %) |